The acquisition is in line with the group’s long-term plans for growth, and will continue to enhance the working relationship with Dr Lim as well as motivate Dr Lim, having commenced his employment with the group since Aug 13, 2018, to further improve the profitability of JLES.
HC Surgical Specialists (HCSS) will be acquiring the remaining 49% stake in Jason Lim Endoscopy and Surgery (JLES) for $9 million.
Upon completion of the acquisition, HCSS will own 100% of JLES.
